| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 0.01 |